This site is intended for Healthcare Professionals only.

RPS Scotland meets minister to discuss pharmacy’s role in reducing harm from drugs


Share post:

RPS Scotland met with the minister for Drugs Policy, Angela Constance, on Wednesday (September 1) to discuss pharmacy’s role in reducing harm from drugs.

Improving availability of naloxone, increasing access to long-acting buprenorphine, timely medication reviews by pharmacists and recording sales of high risk over the counter medicines were other topics discussed in the meeting.

Laura Wilson, RPS Scotland policy lead, said: “We described how pharmacy teams in both community pharmacy and GP practices could administer long-acting buprenorphine.

“Enabling pharmacists to be involved would provide patients with choice about where and when they access buprenorphine, making it more likely to retain people in treatment and consequently reduce drug deaths.”

RPS Scotland stated that naloxone should be made available in all community pharmacies and in all clinical settings.

Clare Morrison, RPS director for Scotland, added: “We pointed out that the current variation across Scotland in where naloxone is available causes confusion and access problems for patients, and asked for this to be addressed through a consideration of a national community pharmacy naloxone service.”

The Scottish Government on August 31, launched a campaign to raise public awareness about drug overdose and the life-saving medication naloxone.

Naloxone is a medication used to reverse the effects of opioids-related overdose.

According to government data, in 2020, 1,339 people died because of drug overdose in Scotland, marking the seventh consecutive year of a record number of drug-related deaths.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

Food prices remain UK consumers’ top concern, FSA report finds

Consumers worried about food affordability were more likely to take food safety risks to save money The Food...

UK life sciences failing to reach its potential despite high R&D investment, new report reveals

Wes Streeting recently announced his plans to bolster the economy through the life sciences sector “The UK remains...

Whooping cough outbreak in England: 9 infant deaths in six months

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise...

Multiple sclerosis: England approves new jab that cuts hospital treatment time by 90%

In addition to significantly reducing treatment time for patients, the new multiple sclerosis injection could also save time...